Announced Fri, 29 May · 20:56 IST

Pursuant to Regulation 30 of the SEBI((Listing Obligations and Disclosure Requirements) Regulations, 2015 , we wish to inform you that the Board of Directors of the Company at their meeting ....

Pat Growth 25pctRevenue Growth 20pctNegative Operating CashflowResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹35.11
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.1-3.7-7.3-3.9-3.9-12.0-26.0
Up moveDown movePending
AI summary

Rajkamal Synthetics Limited reported audited standalone revenue of Rs. 123.67 lac for FY26, down from Rs. 572.47 lac in FY25 (a significant decline), with standalone net profit of Rs. 16.70 lac versus Rs. 32.85 lac in the prior year. On a consolidated basis, the company reported total income of Rs. 1,110.67 lac and net profit of Rs. 27.61 lac for FY26. The company prepared consolidated financials for the first time, having acquired three subsidiaries during the year: Eliraluxe Skincare Private Limited (100% stake), RKR Mines and Minerals Private Limited (100% stake), and Indoframe Industries Private Limited (51% stake). The auditor issued an unmodified (clean) opinion on both standalone and consolidated financial statements. Cash and cash equivalents declined sharply from Rs. 775.38 lac to Rs. 203.56 lac on a consolidated basis.

Likely market impact

The massive standalone revenue decline is explained by the new group structure with newly acquired subsidiaries. However, the negative operating cash flow of Rs. 428.47 lac and declining cash reserves raise concerns about liquidity. The clean audit opinion provides some comfort to investors.